Academic Journal
Q1European Journal of Clinical Microbiology and Infectious Diseases
About European Journal of Clinical Microbiology and Infectious Diseases
European Journal of Clinical Microbiology and Infectious Diseases is a scholarly journal published by Springer Science and Business Media Deutschland GmbH. SCImago 2025 lists it in Q1, with an SJR of 0.998 and H-index of 133.
Coverage: 1988-2026. Research categories: Infectious Diseases (Q1); Medicine (miscellaneous) (Q1); Microbiology (medical) (Q2).
Verified field sources
- Journal Impact Factor: 3.2 — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
- Impact Factor year: 2025 — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
- Editor(s): Laurent Poirel PhD (Editor-in-Chief) — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
Source-backed journal facts
Topics in published research
Bacterial Identification and Susceptibility Testing; Antibiotic Resistance in Bacteria; Antimicrobial Resistance in Staphylococcus; Pneumonia and Respiratory Infections; Streptococcal Infections and Treatments; Antibiotics Pharmacokinetics and Efficacy.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
2,890.00 USD; 4,590.00 EUR
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Serum Borrelia IgG as a rule-out test in suspected lyme neuroborreliosis: a large retrospective cohort study
Al-Hasan Hussein Dos, Anne-Mette Lebech, Jonas Bredtoft Boel, Lene Nielsen et al.
2026-10-02 · DOI: 10.1007/s10096-026-05679-ySex- and age-specific incidence and fraction of hospital contacts for infectious mononucleosis cases in Denmark in 1977–2011
Klaus Rostgaard, Ragnar Kristjánsson, Kathrine Agergård Kaspersen, Christina Mikkelsen et al.
2026-10-02 · DOI: 10.1007/s10096-026-05685-0Risk factors for infection in NDM-colonized patients and applicability of the Giannella Risk Score
O. Lima, M. T. Pérez-Rodríguez, P. M. Álvarez, A. Filgueira et al.
2026-09-30 · DOI: 10.1007/s10096-026-05682-3Standardization and evaluation of artificial intelligence-driven Fourier-transform infrared bio-typing for the discrimination of Escherichia coli and Shigella spp. on genus, species and serogroup level
Miriam Cordovana, Denise Dekker, Andreas Wille, Judith Overhoff et al.
2026-09-30 · DOI: 10.1007/s10096-026-05653-8Double-antigen sandwich ELISA based on chimeric antigens for detection of antibodies to Trypanosoma cruzi in human sera – A phase II study
Natália Erdens Maron Freitas, Felipe Silva Santos Jesus, Randrin Queiroz Viana Ferreira, Edimilson Domingos Silva et al.
2026-09-29 · DOI: 10.1007/s10096-026-05687-yHBV/HCV coinfection and anti-tuberculosis drug-induced liver injury: from risk assessment and exploration of mechanisms to preventive considerations
Xiao-Jing Li, Na Zhang, Qiang Zhang, Rui Chen et al.
2026-09-29 · DOI: 10.1007/s10096-026-05686-zReal-world effectiveness and treatment costs of ceftazidime–avibactam versus colistin–meropenem for ICU-acquired MDR gram-negative infections in liver transplant recipients
Adem Kose, Nisa Candas, Seyma Yasar, Sibel Altunisik Toplu et al.
2026-09-26 · DOI: 10.1007/s10096-026-05677-0Humanizing Zophobas morio larvae microbiota for rapid screening of emerging decolonization strategies against multidrug-resistant bacteria
Chahrazed Belhout, Samanta Freire, Claudia Aldeia, Andrea Endimiani et al.
2026-09-26 · DOI: 10.1007/s10096-026-05674-3Optimizing MALDI-TOF MS for routine dermatophyte identification, including Trichophyton indotineae
Oğuzhan Bingöl, Hazal Kandemir, Engin Kaplan, Nevzat Ünal et al.
2026-09-25 · DOI: 10.1007/s10096-026-05684-1Diagnosis of atypical coagulase-negative staphylococci in native valve endocarditis
David M Mannion
2026-09-23 · DOI: 10.1007/s10096-026-05676-1Impact on blood cultures pre-analytical quality and positivity rate of a key performance indicators digital monitoring approach: a pre–post intervention study
Fabio Arena, Claudio Palmieri, Filippo Allegrucci, Simona Carosati et al.
2026-09-22 · DOI: 10.1007/s10096-026-05678-zSuspected acute bacterial meningitis in adult emergency department: use of imaging before lumbar puncture and association with time to antibiotic initiation — a multicentre retrospective study
Eleonore Roy, Reda Bentayeb, Marie Estelle Cariou, Myrtille Viel et al.
2026-09-22 · DOI: 10.1007/s10096-026-05669-0Validation of an innovative tissue-cage/beads rabbit model for ex vivo determination of minimum levels of Staphylococcus aureus biofilm eradication
Ludivine Coignet, Simon Jamard, Audrey Passaret, Tilia Mézieres et al.
2026-09-16 · DOI: 10.1007/s10096-026-05654-7Effect of an antibiotic stewardship program on antimicrobial use and resistance in a high prescribing, high resistance setting: A single-center, interrupted time series analysis
Michael Samarkos, Antonios Markogiannakis, John Deliolanis, Nikolaos Pantazis et al.
2026-09-15 · DOI: 10.1007/s10096-026-05671-6Development of a rapid diagnostic test for the cefazolin inoculum effect in methicillin-susceptible Staphylococcus aureus: Cefinase disk direct (CDD) test
Sakura Ogawa, Shinnosuke Fukushima, Shuma Tsuji, Kazuyoshi Gotoh et al.
2026-09-15 · DOI: 10.1007/s10096-026-05672-5Newly recognized typical microorganisms in intracardiac prosthetic material-related infective endocarditis: evidence behind their inclusion in the 2023 Duke-ISCVID criteria
Eric Ruiz Rebelo, Inês Moreira Sousa, Maria Ana Quadros Flores, Carla Mimoso Santos et al.
2026-09-14 · DOI: 10.1007/s10096-026-05675-2A Rapid Molecular Detection Method for Streptococcus agalactiae Based on Bacteriophage Lysin Lysis and Real-Time PCR
Huijun Zhu, Xiaoying Zeng, Xuanmei Huang, Yixuan Liu et al.
2026-09-12 · DOI: 10.1007/s10096-026-05666-3First evaluation of Thermo Scientific Brilliance Candida 2 Agar for presumptive Candidozyma auris identification and comparison with CHROMagar Candida Plus
Ilvana Caklovica Kucukkaya, Berkay Yuksel, Mehmet Ilker Tosun, Nesibe Nur Yurttakal et al.
2026-09-11 · DOI: 10.1007/s10096-026-05667-2Therapeutic drug monitoring of high-dosage intravenous flucloxacillin and mortality in patients with Staphylococcus aureus bacteremia: a retrospective cohort study using inverse probability weighting
D. T. P. Buis, J. L. Wu, S. Douiyeb, C. H. van Werkhoven et al.
2026-09-10 · DOI: 10.1007/s10096-026-05670-7A multi-site observational study of rationality assessment for carbapenem use in China: carbapenem stewardship opportunities
Jingwen Li, Guirong Xiao, Siming Tang, Jie Wan et al.
2026-09-10 · DOI: 10.1007/s10096-026-05660-9Reviews
Community Reviews
Version History
October 4, 2026 at 8:59 pm
October 2, 2026